Concurrent immunoradiotherapy with Toripalimab versus concurrent chemoradiotherapy with S-1 in older patients with esophageal squamous cell carcinoma: a retrospective cohort study. [PDF]
Huang Y +6 more
europepmc +1 more source
International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and Challenges. [PDF]
Chan A +11 more
europepmc +1 more source
The neutrophil-to-lymphocyte ratio as a marker of immunosenescence and COVID-19 outcomes in the elderly: A narrative review. [PDF]
Gasmi M +4 more
europepmc +1 more source
Treatment-free remission in MS: long-term disease control with cladribine tablets. [PDF]
Wiendl H +10 more
europepmc +1 more source
Late-onset combined immunodeficiency and bone marrow failure in severe autoimmune hepatitis: a case report. [PDF]
Sahbani F +7 more
europepmc +1 more source
Impact of lymphopenia and hypogammaglobulinemia on outcomes in neutropenic patients with hematological malignancies. [PDF]
Van de Louw A, King L, Nickolich M.
europepmc +1 more source
Sequential chemo-durvalumab, reduced-dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial). [PDF]
Agustoni F +14 more
europepmc +1 more source
Ramsay-Hunt Syndrome in Patients Undergoing Dose-Dense Chemotherapy in the Perioperative Period of Breast Cancer: Two Case Reports. [PDF]
Kanaya E +7 more
europepmc +1 more source
Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia. [PDF]
Ghosh S +24 more
europepmc +1 more source
Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China. [PDF]
Tan H +7 more
europepmc +1 more source

